In addition, uremia induced suppression of DMP1, and hence increments of FGF23 may explain the clinical observation that in more early stages of CKD, FGF23 and phosphate levels appear to diverge, pointing to another inducer of FGF23 than phosphate itself, namely suppressed DMP1 [61]. Here, FGF23 is linked to chronic kidney disease.